Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials

Citation
Singh AK, Singh R. Diabetes Metab Syndr 2020;14:181–7.